Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin (2024)
- Authors:
- USP affiliated authors: FERREIRA, LEONARDO LUIZ GOMES - IFSC ; ANDRICOPULO, ADRIANO DEFINI - IFSC ; CHELUCCI, RAFAEL CONSOLIN - IFSC
- Unidade: IFSC
- DOI: 10.1182/blood-2024-208290
- Subjects: METABOLISMO CELULAR; HEMOGLOBINAS; CRISTALOGRAFIA
- Language: Inglês
- Imprenta:
- Publisher place: Washington, DC
- Date published: 2024
- Source:
- Conference titles: American Society of Hematology Annual Meeting
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
PASTRE, Victor Gabriel de Faria et al. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin. Blood. Washington, DC: Instituto de Física de São Carlos, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2024-208290. Acesso em: 31 mar. 2026. , 2024 -
APA
Pastre, V. G. de F., Pavan, A. R., Lanaro, C., Albuquerque, D. M. de, Chelucci, R. C., Ferreira, L. L. G., et al. (2024). Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin. Blood. Washington, DC: Instituto de Física de São Carlos, Universidade de São Paulo. doi:10.1182/blood-2024-208290 -
NLM
Pastre VG de F, Pavan AR, Lanaro C, Albuquerque DM de, Chelucci RC, Ferreira LLG, Andricopulo AD, Santos JL dos, Costa FF. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin [Internet]. Blood. 2024 ; No 2024 3868-3869.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1182/blood-2024-208290 -
Vancouver
Pastre VG de F, Pavan AR, Lanaro C, Albuquerque DM de, Chelucci RC, Ferreira LLG, Andricopulo AD, Santos JL dos, Costa FF. Novel selective HDAC1/2 inhibitor 2-aminobenzamide derivative potently induces fetal hemoglobin [Internet]. Blood. 2024 ; No 2024 3868-3869.[citado 2026 mar. 31 ] Available from: https://doi.org/10.1182/blood-2024-208290 - Design, synthesis and in vitro evaluation of a series of arylmorpholine derivative compounds against chagas disease
- Design and synthesis of boronic chalcones with dual anticancer and anti-inflammatory activity
- Potente reativação da produção de hemoglobina fetal por novo inibidor seletivo de histona deacetilase 1 e 2
- Novel deferasirox analogues designed as iron chelating agents for iron overload treatment
- Optimized HDAC inhibitors induce robust γ-globin gene expression and exhibit superior efficacy to hydroxyurea in Sickle Cell Disease models
- Discovery of arylpiperazines with broad-spectrum antimicrobial activity and favorable pharmacokinetic profiles
- Evaluation and discovery of novel benzothiazole derivatives as promising hits against Leishmania infantum
- Hit-to-lead optimization of a 2-aminobenzimidazole series as new candidates for chagas disease
- Hit-to-lead optimization of a benzene sulfonamide series for potential antileishmanial agents
- Novel brominated vinylic fatty acids effectively inhibit the leishmania topoisomerase IB enzyme mediated by halogen bond formation
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
3234727.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
